ArticleCellular and molecular neurobiology2026

Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.

Katharina Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.